Geraldine T. Farrell
Keine laufenden Positionen mehr
Profil
Geraldine T.
Farrell served as Secretary, VP-Operations & General Counsel at Nexvet Biopharma Plc.
She was also a Member of the Australian Red Cross Blood Service.
From 2013 to 2018, she worked at Nexvet Australia Pty Ltd.
as Vice President-Operations & General Counsel.
In 2019, she became Secretary & Chief Compliance Officer at Cann Group Ltd.
Farrell received her undergraduate and graduate degrees from Monash University.
Ehemalige bekannte Positionen von Geraldine T. Farrell
| Unternehmen | Position | Ende |
|---|---|---|
| CANN GROUP LIMITED | Compliance Officer | 25.10.2022 |
Nexvet Australia Pty Ltd.
 Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Chief Operating Officer | 01.01.2018 |
| NEXVET BIOPHARMA PUBLIC LIMITED CO | Chief Operating Officer | 31.07.2017 |
Australian Red Cross Blood Service
 Australian Red Cross Blood Service Internet Software/ServicesTechnology Services The Australian Red Cross Blood Service is an organization that emphasizes the importance of blood donation. The organization is based in Sydney, Australia. The Australian company's mission is to ensure that blood is available to those who need it, with the knowledge that someone requires a blood donation every 24 seconds. | Corporate Officer/Principal | - |
Ausbildung von Geraldine T. Farrell
| Monash University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CANN GROUP LIMITED | Process Industries |
| Private Unternehmen | 3 |
|---|---|
Nexvet Biopharma Plc
 Nexvet Biopharma Plc Pharmaceuticals: MajorHealth Technology Nexvet Biopharma Plc engaged in the provision of integrated biopharmaceutical business. It focused on transforming the therapeutic market for companion animals, such as dogs and cats, by developing and commercializing novel, species-specific biologics. The company was founded in September 2014 and was headquartered in Dublin, Ireland. | Health Technology |
Australian Red Cross Blood Service
Australian Red Cross Blood Service Internet Software/ServicesTechnology Services The Australian Red Cross Blood Service is an organization that emphasizes the importance of blood donation. The organization is based in Sydney, Australia. The Australian company's mission is to ensure that blood is available to those who need it, with the knowledge that someone requires a blood donation every 24 seconds. | Technology Services |
Nexvet Australia Pty Ltd.
Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Health Technology |
